We are live on !
Find out more
CWM
Cahill Wealth Management Portfolio holdings
AUM
$196M
Turnover
4%
1-Year Est. Return
8.5%
This Fund
S&P 500
This Quarter Est. Return
-4.13%
1 Year Est. Return
+8.5%
3 Year Est. Return
+24.65%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$112M
AUM Growth
-$6.26M
(-5.3%)
Cap. Flow
-$696K
Cap. Flow % of AUM
Cap. Flow %
-0.62%
Top 10 Holdings %
Top 10 Hldgs %
80.29%
Holding
43
New
2
Increased
17
Reduced
16
Closed
2
Avg Time Held
0.4
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.75M |
| 2 |
U.S. Core Equity 2 Portfolio ETF Class Shares
DFAC
|
+$1.17M |
| 3 |
ClearPoint Neuro
CLPT
|
+$432K |
| 4 |
XPEL
XPEL
|
+$295K |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$291K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ChemoCentryx, Inc.
CCXI
|
+$1.69M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.21M |
| 3 |
Dimensional US Core Equity Market ETF
DFAU
|
+$784K |
| 4 |
Dimensional International Core Equity Market ETF
DFAI
|
+$355K |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$321K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 84.02% |
| 2 | Financials | 8.51% |
| 3 | Healthcare | 2.87% |
| 4 | Technology | 2.32% |
| 5 | Consumer Discretionary | 2.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
iShares Core S&P 500 ETF
IVV
$880B
| $47M | 41.94% |
130,965
-3,030
| -2% | -$1.21M |
2022 Q1
2 quarters
|
|
2
Berkshire Hathaway Class A
BRK.A
$1.14T
| $8.94M | 7.98% |
22
| – | – |
2022 Q1
2 quarters
|
|
3
Vanguard Morningstar Total Stock Market ETF
VTI
$689B
| $7.27M | 6.49% |
40,521
-36
| -0.1% | -$7.18K |
2022 Q1
2 quarters
|
|
|
4
iShares Core S&P Mid-Cap ETF
IJH
$121B
| $5.74M | 5.12% |
130,890
+6,025
| +5% | +$291K |
2022 Q1
2 quarters
|
|
|
5
iShares Core S&P Small-Cap ETF
IJR
$102B
| $5.74M | 5.12% |
65,831
-3,301
| -5% | -$321K |
2022 Q1
2 quarters
|
|
6
Vanguard Intermediate-Term Bond ETF
BIV
$28.4B
| $4.85M | 4.33% |
66,009
+26
| +0% | +$2.01K |
2022 Q1
2 quarters
|
|
7
iShares Core US Aggregate Bond ETF
AGG
$138B
| $3.5M | 3.12% |
36,288
-805
| -2% | -$81.4K |
2022 Q1
2 quarters
|
|
8
Apple
AAPL
$5.01T
| $2.6M | 2.32% |
18,836
+51
| +0.3% | +$8K |
2022 Q1
2 quarters
|
|
|
9
U.S. Core Equity 2 Portfolio ETF Class Shares
DFAC
$48.8B
| $2.55M | 2.28% |
114,650
+47,501
| +71% | +$1.17M |
2022 Q1
2 quarters
|
|
|
10
XPEL
XPEL
$1.21B
| $1.75M | 1.56% |
27,199
+4,542
| +20% | +$295K |
2022 Q1
2 quarters
|
|
11
iShares MSCI EAFE Small-Cap ETF
SCZ
$12.8B
| $1.63M | 1.45% |
33,387
-609
| -2% | -$33.4K |
2022 Q1
2 quarters
|
|
12
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
| $1.6M | 1.43% |
57,685
+15
| +0% | +$461 |
2022 Q1
2 quarters
|
|
|
13
State Street SPDR S&P 500 ETF Trust
SPY
$806B
| $1.57M | 1.4% |
+4,403
| New | +$1.75M |
2022 Q3
0 quarters
|
|
|
14
ClearPoint Neuro
CLPT
$277M
| $1.37M | 1.22% |
132,188
+32,816
| +33% | +$432K |
2022 Q1
2 quarters
|
|
15
Vanguard Morningstar Small-Cap ETF
VB
$76.9B
| $1.34M | 1.2% |
7,872
-663
| -8% | -$125K |
2022 Q1
2 quarters
|
|
16
Vanguard FTSE Developed Markets ETF
VEA
$228B
| $1.29M | 1.15% |
35,474
-371
| -1% | -$15.1K |
2022 Q1
2 quarters
|
|
17
Stryker
SYK
$113B
| $1.04M | 0.93% |
5,120
-417
| -8% | -$87.7K |
2022 Q1
2 quarters
|
|
18
U.S. Small Cap Value Portfolio ETF Class Shares
DFSV
$8.11B
| $976K | 0.87% |
44,796
+6,714
| +18% | +$161K |
2022 Q2
1 quarter
|
|
19
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14B
| $932K | 0.83% |
21,138
-433
| -2% | -$21.2K |
2022 Q1
2 quarters
|
|
20
Schwab US Broad Market ETF
SCHB
$44.4B
| $894K | 0.8% |
63,930
+237
| +0.4% | +$3.69K |
2022 Q1
2 quarters
|
|
21
Vanguard FTSE All-World ex-US ETF
VEU
$67B
| $770K | 0.69% |
17,366
-9
| -0.1% | -$445 |
2022 Q1
2 quarters
|
|
22
Vanguard Total Bond Market
BND
$163B
| $767K | 0.68% |
10,753
+486
| +5% | +$36.4K |
2022 Q2
1 quarter
|
|
23
Amazon
AMZN
$2.7T
| $647K | 0.58% |
5,730
+150
| +3% | +$19K |
2022 Q1
2 quarters
|
|
24
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$18.9B
| $620K | 0.55% |
3,636
-840
| -19% | -$159K |
2022 Q1
2 quarters
|
|
25
iShares Russell Mid-Cap Growth ETF
IWP
$18.8B
| $614K | 0.55% |
7,836
-1,835
| -19% | -$158K |
2022 Q1
2 quarters
|
|
Similar funds
CW
LA
GWA
NC
SC
CCM
PC
SAM
Cahill Wealth Management's Q3 2022 Portfolio in Review
As of Q3 2022, Cahill Wealth Management held 43 positions worth $112M, down 5.3% from $118M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Cahill Wealth Management's Q3 2022 filing shows 2 new, 17 increased, 16 reduced and 2 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 4,403 shares worth $1.57M. The largest sale was ChemoCentryx, Inc., an estimated $1.69M.
By sector, the portfolio is most concentrated in Miscellaneous at 84% of assets, down from 84% a quarter earlier, followed by Financials and Healthcare.
- Cahill Wealth Management's largest Q3 2022 buy was State Street SPDR S&P 500 ETF Trust: 4,403 shares worth $1.57M.
- Cahill Wealth Management added most to U.S. Core Equity 2 Portfolio ETF Class Shares in Q3 2022, an estimated $1.17M increase.
- Cahill Wealth Management's biggest Q3 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.21M.
- Cahill Wealth Management fully exited ChemoCentryx, Inc. in Q3 2022, selling an estimated $1.69M.
- Cahill Wealth Management's ten largest holdings make up 80% of its $112M portfolio in Q3 2022.
- Cahill Wealth Management opened 2 new positions and closed 2 in Q3 2022.
- Cahill Wealth Management's portfolio value fell 5.3% quarter-over-quarter to $112M.
Based on Cahill Wealth Management's 13F filing for Q3 2022, filed 10 Nov 2022.